Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen

NCT00191269 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: gemcitabine
DRUG: gemcitabine

Sponsor

Eli Lilly and Company